Source: centralcharts

Press Release: MSPharma : EQS-News: MS Pharma becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region

EQS-News: Formycon AG / Key word(s): Agreement MS Pharma becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region 09.12.2024 / 06:30

Read full article »
MSPharma's Competitors | MSPharma's News | MSPharma's Financials
Stay up-to-date with the latest news on MSPharma
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Essam Farouk's photo - CEO of MSPharma

CEO

Essam Farouk

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on MSPharma